XML 35 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Details) (USD $)
0 Months Ended 12 Months Ended 0 Months Ended
Sep. 17, 2010
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Minimum [Member]
Dec. 31, 2013
Maximum [Member]
Dec. 31, 2013
Cost of revenues [Member]
Dec. 31, 2012
Cost of revenues [Member]
Dec. 31, 2013
Sales and marketing [Member]
Dec. 31, 2012
Sales and marketing [Member]
Dec. 31, 2013
Technology support [Member]
Dec. 31, 2012
Technology support [Member]
Dec. 31, 2013
General and administrative [Member]
Dec. 31, 2012
General and administrative [Member]
Dec. 31, 2013
Stock Options [Member]
Dec. 31, 2012
Stock Options [Member]
Dec. 31, 2013
Service-Based Options [Member]
Dec. 31, 2012
Service-Based Options [Member]
Dec. 31, 2013
Performance-Based Options [Member]
Dec. 31, 2012
Performance-Based Options [Member]
Dec. 31, 2013
Market Condition Options [Member]
Dec. 31, 2012
Market Condition Options [Member]
Dec. 31, 2009
Market Condition Options [Member]
Sep. 17, 2010
Warrant [Member]
Dec. 31, 2013
Warrant [Member]
Dec. 31, 2013
Promissory note [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                                  
Aggregate shares of common stock reserved for future issuance (in shares)   388,971                       400,000                      
Share-based compensation expense   $ 706,000 $ 915,000     $ 50,000 $ 46,000 $ 153,000 $ 225,000 $ 206,000 $ 288,000 $ 297,000 $ 356,000                        
Amount capitalized to internal use software   2,000 5,000                                            
Total share-based compensation expense   704,000 910,000                                            
Unrecognized compensation expense   600,000 800,000                                            
Weighted average period for recognition of unrecognized compensation expense   1 year 6 months                                              
Contractual term of options       7 years 10 years                                        
Vesting Period   3 years                                              
Weighted average grant date fair value (in dollars per share)                           $ 2.57 $ 2.37 $ 2.37 $ 2.31 $ 2.19 $ 2.39     $ 0.97      
Weighted average assumptions [Abstract]                                                  
Expected volatility (in hundredths)   65.00% 84.00%                                            
Expected risk-free interest rate (in hundredths)   0.80% 0.60%                                            
Expected life (years)   4 years 3 months 18 days 4 years 2 months 12 days                                            
Number of Options [Roll Forward]                                                  
Outstanding at December 31, 2011 (in shares)   1,559,339                                              
Granted (in shares)   289,258                           113,500 80,900 87,117 249,199     213,650      
Exercised (in shares)   (54,337)                       54,337 10,982         5,879 9,206        
Forfeited or expired (in shares)   (162,457)                                              
Outstanding at December 31, 2012 (in shares)   1,631,803 1,559,339                                            
Vested and expected to vest at December 31, 2012 (in shares)   1,599,601                                              
Exercisable at December 31, 2012 (in shares)   1,247,384                                              
Weighted Average Exercise Price per Share [Roll Forward]                                                  
Outstanding at December 31, 2011 (in dollars per share)   $ 6.12                                              
Granted (in dollars per share)   $ 5.22                               $ 4.00 $ 3.90     $ 1.75      
Exercised (in dollars per share)   $ 3.92                       $ 3.92 $ 1.97                    
Forfeited or expired (in dollars per share)   $ 10.60                                              
Outstanding at December 31, 2012 (in dollars per share)   $ 5.59 $ 6.12                                            
Vested and expected to vest at December 31, 2012 (in dollars per share)   $ 5.59                                              
Exercisable at December 31, 2012 (in dollars per share)   $ 5.78                                              
Weighted Average Remaining Contractual Term [Roll Forward]                                                  
Outstanding   4 years 10 months 24 days 5 years 7 months 6 days                                            
Vested and expected to vest at December 31, 2012   4 years 10 months 24 days                                              
Exercisable at December 31, 2012   4 years 6 months                                              
Aggregate Intrinsic Value [Roll Forward]                                                  
Outstanding   16,453,000                                              
Vested and expected to vest at December 31, 2012   16,142,000                                              
Exercisable at December 31, 2012   12,541,000                                              
Number of options vested based on revenues and EBITDA (in shares)                                   83,398 161,394            
Total intrinsic value of options exercised                           60,000 21,000                    
Number of rights to purchase each share of common stock (in shares)   5                                              
Number of Series A Participating Preferred Stock to be purchased on entitlement of right   0.001                                              
Price of Series A Junior Participating Preferred Stock (in dollars per share)   $ 8.00                                         $ 4.65    
Percentage of ownership to trigger rights (in hundredths)   4.90%                                              
Warrants to purchase common stock (in shares) 400,000                                                
Exercise price of warrants (in dollars per share)   $ 8.00                                         $ 4.65    
Fair value of warrant (in dollars per share)                                             $ 3.15    
Warrant to purchase 2,000,000 shares of Company Common Stock $ 1,260,000                                                
Risk free rate (in hundredths)                                             2.30%    
Stock price volatility (in hundredths) 77.50%                                           77.50%    
Term                                             8 years 0 months 14 days    
Shares of common stock reserved for future issuance [Abstract]                                                  
Stock options outstanding (in shares)   1,631,803 1,559,339                                            
Authorized (in shares)   388,971                       400,000                      
Reserved for future issuance (in shares)   3,496,042                                           400,000 1,075,268